Megval 50 mg Injection

chemotherapy drug

Description

Megval 50 mg Injection by Emcure is a chemotherapy drug used to treat different cancers including myeloma, melanoma and ovarian cancer.Its generic name is Melphalan, and it is popularly known as Alkeran in other parts of the world. It is classified as an alkylating agent. It is also available in tablet form

Manufacturer: Emcure

Additional Information

Administration:

As a pill by mouth. Tablets come in a 2mg size.
Take medication on an empty stomach (1 hour before to 2 hours after meals).
As an injection or infusion into the vein (intravenous, IV).
The amount of melphalan that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition being treated. Your doctor will determine your dose and schedule.

Side Effects

Side Effects:

Low blood counts. Your white and red blood cells and platelets may temporarily decrease. This can put you at increased risk for infection, anemia and/or bleeding. This effect may be prolonged and cumulative.
Nausea and vomiting. (mild with regular dosing, can be severe with high-dose therapy)

Megval 50 mg Injection

Description

Additional Information

Side Effects

Pack Size

Related products

Adcertis Brentuximab vedotin 50 mg

PERJETA pertuzumab 420 mg Injection

KADCYLA Trastuzumab 100mg & 160mg Injection

PEGASTA Pegfilgrastim 6mg